Get Help From Ennis & Ennis P.A. Today Contact Us

Essure Sisters Return To Washington

Holly Kelly Ennis Oct. 1, 2017

This past week, members of the Essure Problems Group travelled from around the country to Washington D.C. to rally in support of H.R. 2164, The Medical Device Safety Act of 2017 (MDSA 2017) and lobby with members of Congress in an effort to get this important legislation passed. They were joined by  patient advocates from the Breast Implant Victim Advocacy Group as well as advocates injured by mesh implants.   The group spent several hours in between the Capital and U. S. Supreme Court buildings rallying and raising awareness for medical device safety and MDSA 2017.

Immediately after rallying, the group transitioned to a well-attended press conference presented by several of the co-sponsors of MDSA 2017. The Medical Device Safety Act of 2017 was introduced in the house on April 26, 2017 by Congressman Brian Fitzpatrick. It is a bi-partisan bill currently co-sponsored by Rosa DeLauro, Louise Slaughter, and Jan Schakowsky. The bill would amend the Federal Food, Drug, and Cosmetic Act with respect to liability under State and local requirements respecting all Class III devices, including, but not limited to, Essure, nerve stimulators, hip implants, defibrillators, pacemakers, infusion pumps, surgical mesh, cochlear implants, and breast implants. The purpose of this bill is to restore a patient’s right to litigation should he/she be harmed by a Class III medical device.

The press conference was a resounding success and the out-pouring of emotions deeply touched Congresswomen DeLauro, Slaughter and Schakowsky, who were both touched and horrified by the stories shared and promised full support for the pending legislation. After the media aired stories concerning the rally and press conference, the Medical Device Manufacturers Association (MDMA) immediately released the following statement to the press regarding MDSA 2017.

“The FDA represents the gold standard when it comes to providing safe and effective medical technologies for patients and providers. Replacing the expert opinions of scientists, physicians, engineers and the trained professionals at the FDA who have dedicated their careers to patient safety with the lay opinion of a jury is simply not prudent."

                                                      ~Mark Leahey, President, MDMA

This arrogant and condescending statement has angered victims of Class III medical devices across the country. If manufacturers are confident regarding the safety and efficacy of their products, they shouldn’t be afraid to defend them in court, and they most certainly should not be exempt from being held accountable for their failures. All persons interested in the passing of this vitally important bill are urged to sign the Petition2Congress and demand that members of Congress  pass this vital legislation.

What remains clear is that the Essure Problems Group continues to gain momentum. It is mobilizing members of other groups who were injured by Class III devices and will continue their fight until Essure is removed from the market in the United States and patients injured by Class III devices have an easier pathway to civil litigation.  If you or a loved one have been injured by Essure, contact attorney Holly Ennis at or visiting our website at